Nitin Joshi, PhD

home / authors / nitin-joshi-phd

Articles

An Inside Look in the Development of CGB-500 For Atopic Dermatitis Treatment

An Inside Look in the Development of CGB-500 For Atopic Dermatitis Treatment

Lauren Buchanan, MA, Managing Editor;Nitin Joshi, PhD
March 5th 2024

Nitin Joshi, PhD, shared CAGE Bio’s development of CGB-500 and why phase 2 EASI scores have the company’s scientific advisory board optimistic.

Latest Updated Articles

2 KOLs are featured in this series.
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
POLL: “Lip Flips” or Lip Filler? Analyzing the Latest Trends in Lip Augmentation
Published: February 28th 2025 | Updated: May 8th 2025
POLL: “Lip Flips” or Lip Filler? Analyzing the Latest Trends in Lip Augmentation
CT-P39 is Just as Effective as Omalizumab for Chronic Spontaneous Urticaria Treatment
Published: January 23rd 2025 | Updated: May 8th 2025
CT-P39 is Just as Effective as Omalizumab for Chronic Spontaneous Urticaria Treatment
The Complex World of Urticaria: Insights from Jason Hawkes, MD, MS
Published: February 13th 2025 | Updated: May 8th 2025
The Complex World of Urticaria: Insights from Jason Hawkes, MD, MS
Q&A: Thomas Casale, MD, Discusses Abstract on Dupilumab and Significant Itch, Hive Reduction in Chronic Spontaneous Urticaria
Published: March 3rd 2025 | Updated: May 8th 2025
Q&A: Thomas Casale, MD, Discusses Abstract on Dupilumab and Significant Itch, Hive Reduction in Chronic Spontaneous Urticaria
Q&A: Jonathan Bernstein, MD, FAAAAI, Discusses Advances in Chronic Spontaneous Urticaria Treatments and AAAAI Data
Published: March 5th 2025 | Updated: May 8th 2025
Q&A: Jonathan Bernstein, MD, FAAAAI, Discusses Advances in Chronic Spontaneous Urticaria Treatments and AAAAI Data
© 2025 MJH Life Sciences

All rights reserved.